UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P121 Primary Chemotherapy with Bevacizumab for Locally Advanced Triple Negative Breast Cancer

Breast (Edinburgh), 2023-04, Vol.68, p.S61-S61

2023

Volltextzugriff (PDF)

Choosing Wisely Campaign: Radiographic Surveillance in Triple Negative Breast Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E13-E13

2015

Volltextzugriff (PDF)

The Influence of Race and Hormone Receptor Status on Recurrence in Patients With Ductal Carcinoma In Situ (DCIS)

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S234-S235

2012

Volltextzugriff (PDF)

The Influence of Race on Locoregional Recurrence (LRR) in BRCA Mutation-Positive Triple-Negative Breast Cancer Patients

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S224-S224

2013

Volltextzugriff (PDF)

Dosimetric Comparison of Supine vs. Prone Position Utilizing Traditional Linac-Based Stereotactic Body Radiation Therapy for Accelerated Partial Breast Irradiation

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e12

2022

Volltextzugriff (PDF)

The Impact of Radiation Dose to the Heart During Treatment with Concurrent Trastuzumab on the Development of Early Cardiac Events: A Dosimetric Analysis

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S225-S225

2010

Volltextzugriff (PDF)

Breast Stereotactic Body Radiation Therapy (SBRT) Reduces Organ at Risk Exposure, Treatment Time and Duration in Partial Breast Irradiation

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e215-e215

2021

Volltextzugriff (PDF)

Abstract P5-15-03: Withdrawn

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-15-03

2018

Volltextzugriff (PDF)

Specimen radiographs assist in identifying and assessing resection margins of occult breast carcinomas

Clinical imaging, 2010-03, Vol.34 (2), p.160-160

2010

Volltextzugriff (PDF)

Abstract PD3-07: A phase II pre-surgical trial of lapatinib for the treatment of women with HER2 positive or EGFR positive ductal carcinoma in situ

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.PD3-07-PD3-07

2019

Volltextzugriff (PDF)

Who Should Not Receive Chemotherapy? Data From American Databases and Trials

Journal of the National Cancer Institute. Monographs, 2001, Vol.2001 (30), p.109-113

2001

Volltextzugriff (PDF)

Nuclear Localization of KLF4 Is Associated with an Aggressive Phenotype in Early-Stage Breast Cancer

Clinical cancer research, 2004-04, Vol.10 (8), p.2709-2719

2004

Volltextzugriff (PDF)

Options for management of the axillary lymph nodes in breast cancer

Breast (Edinburgh), 2001-08, Vol.10, p.62-68

2001

Volltextzugriff (PDF)

Abstract S6-05: A phase II trial of neoadjuvant palbociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with anastrozole for clinical stage 2 or 3 estrogen receptor positive HER2 negative (ER+HER2-) breast cancer (BC)

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S6-S6-05

2016

Volltextzugriff (PDF)

P5-11-07: Receptor Concordance in Triple-Negative Breast Cancer (TNBC) Recurrences

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P5-P5-11-07

2011

Volltextzugriff (PDF)

Abstract P3-03-03: A tri-modality imaging assessment algorithm to evaluate neoadjuvant therapy response in patients with operable breast cancer

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P3-P3-03-03

2012

Volltextzugriff (PDF)

Abstract P1-15-02: Long term follow-up of the neo-adjuvant pilot trial evaluating activity of letrozole in combination with bevacizumab in post-menopausal women with newly diagnosed estrogen and/or progesterone receptor positive primary breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P1-P1-15-02

2013

Volltextzugriff (PDF)

P3-07-06: Prognostic Utility of Upfront Nodal Staging Prior to Neoadjuvant Chemotherapy: The UAB Experience

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P3-P3-07-06

2011

Volltextzugriff (PDF)

P3-14-31: Preoperative Chemotherapy and Bevacizumab for Locally Advanced HER-2 Negative Breast Cancer Followed by Prolonged Postoperative Bevacizumab for Those with Less Than Complete Pathologic Response

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P3-P3-14-31

2011

Volltextzugriff (PDF)

P3-14-26: The Effect of Biologic Subtype in Patients Treated with Neoadjuvant Chemotherapy: A UAB Experience

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P3-P3-14-26

2011

Volltextzugriff (PDF)

An update on the dosimetric analysis of concurrent radiation therapy and trastuzumab on early cardiac events

Journal of clinical oncology, 2011-09, Vol.29 (27_suppl), p.121-121

2011

Volltextzugriff (PDF)

Breast cancer risk reduction

Journal of the National Comprehensive Cancer Network, 2010-10, Vol.8 (10), p.1112-1146

2010

Volltextzugriff (PDF)

Abstract P2-18-09: TBCRC 013: A prospective analysis of the role of surgery in stage IV breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P2-P2-18-09

2013

Volltextzugriff (PDF)

Abstract P5-10-19: The Influence of Time to Completion of Chemotherapy on Survival in Patients with Triple Negative Stage III Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P5-P5-10-19

2010

Volltextzugriff (PDF)

Abstract P4-11-04: The Influence of Radiation on Survival in Patients with Triple Negative Stage II Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-11-04

2010

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(59)
Tagungsberichte
(2)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

Humans
(13)
Science & Technology
(13)
Female
(12)
Life Sciences & Biomedicine
(10)
Middle Aged
(8)
Oncology
(8)
Aged
(7)
Adult
(5)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Prognosis
(5)
Radiology
(5)
Tumors
(5)
Aged, 80 And Over
(4)
Breast Neoplasms - Pathology
(4)
Hematology, Oncology And Palliative Medicine
(4)
Immunohistochemistry
(4)
Antineoplastic Agents - Therapeutic Use
(3)
Biopsy
(3)
Breast Cancer
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P121 Primary Chemotherapy with Bevacizumab for Locally Advanced Triple Negative Breast Cancer

Choosing Wisely Campaign: Radiographic Surveillance in Triple Negative Breast Cancer

The Influence of Race and Hormone Receptor Status on Recurrence in Patients With Ductal Carcinoma In Situ (DCIS)

The Influence of Race on Locoregional Recurrence (LRR) in BRCA Mutation-Positive Triple-Negative Breast Cancer Patients

Dosimetric Comparison of Supine vs. Prone Position Utilizing Traditional Linac-Based Stereotactic Body Radiation Therapy for Accelerated Partial Breast Irradiation

The Impact of Radiation Dose to the Heart During Treatment with Concurrent Trastuzumab on the Development of Early Cardiac Events: A Dosimetric Analysis

Breast Stereotactic Body Radiation Therapy (SBRT) Reduces Organ at Risk Exposure, Treatment Time and Duration in Partial Breast Irradiation

Abstract P5-15-03: Withdrawn

Specimen radiographs assist in identifying and assessing resection margins of occult breast carcinomas

Abstract PD3-07: A phase II pre-surgical trial of lapatinib for the treatment of women with HER2 positive or EGFR positive ductal carcinoma in situ

Who Should Not Receive Chemotherapy? Data From American Databases and Trials

Nuclear Localization of KLF4 Is Associated with an Aggressive Phenotype in Early-Stage Breast Cancer

Options for management of the axillary lymph nodes in breast cancer

Abstract S6-05: A phase II trial of neoadjuvant palbociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with anastrozole for clinical stage 2 or 3 estrogen receptor positive HER2 negative (ER+HER2-) breast cancer (BC)

P5-11-07: Receptor Concordance in Triple-Negative Breast Cancer (TNBC) Recurrences

Abstract P3-03-03: A tri-modality imaging assessment algorithm to evaluate neoadjuvant therapy response in patients with operable breast cancer

Abstract P1-15-02: Long term follow-up of the neo-adjuvant pilot trial evaluating activity of letrozole in combination with bevacizumab in post-menopausal women with newly diagnosed estrogen and/or progesterone receptor positive primary breast cancer

P3-07-06: Prognostic Utility of Upfront Nodal Staging Prior to Neoadjuvant Chemotherapy: The UAB Experience

P3-14-31: Preoperative Chemotherapy and Bevacizumab for Locally Advanced HER-2 Negative Breast Cancer Followed by Prolonged Postoperative Bevacizumab for Those with Less Than Complete Pathologic Response

P3-14-26: The Effect of Biologic Subtype in Patients Treated with Neoadjuvant Chemotherapy: A UAB Experience

An update on the dosimetric analysis of concurrent radiation therapy and trastuzumab on early cardiac events

Breast cancer risk reduction

Abstract P2-18-09: TBCRC 013: A prospective analysis of the role of surgery in stage IV breast cancer

Abstract P5-10-19: The Influence of Time to Completion of Chemotherapy on Survival in Patients with Triple Negative Stage III Breast Cancer

Abstract P4-11-04: The Influence of Radiation on Survival in Patients with Triple Negative Stage II Breast Cancer

Suchergebnisse filtern